Cargando…

SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment

Detalles Bibliográficos
Autores principales:	Rebeaud, Mathieu E., Zores, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193267/ https://www.ncbi.nlm.nih.gov/pubmed/32391371 http://dx.doi.org/10.3389/fmed.2020.00184

Ejemplares similares

COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
por: Zores, Florian, et al.
Publicado: (2020)

Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
por: Pastick, Katelyn A, et al.
Publicado: (2020)

Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
por: Uzunova, Katya, et al.
Publicado: (2020)

Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

Chloroquine drops against SARS-CoV-2 infection
por: Kumar, Jogender, et al.
Publicado: (2022)

Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence
por: Visvabharathy, Lavanya, et al.
Publicado: (2022)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2?
por: Kassi, Eva N., et al.
Publicado: (2020)

Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
por: Afsar, Mohammad, et al.
Publicado: (2022)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

Recent changes in the mutational dynamics of the SARS-CoV-2 main protease substantiate the danger of emerging resistance to antiviral drugs
por: Parigger, Lena, et al.
Publicado: (2022)

Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
por: Smit, Cornelis, et al.
Publicado: (2020)

Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
por: Guo, Yong, et al.
Publicado: (2021)

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Growth, Antigenicity, and Immunogenicity of SARS-CoV-2 Spike Variants Revealed by a Live rVSV-SARS-CoV-2 Virus
por: Ding, Limin S., et al.
Publicado: (2022)

Genomic characterization of SARS-CoV-2 in Egypt
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature
por: De Luca, Pietro, et al.
Publicado: (2021)

Reviving chloroquine for anti-SARS-CoV-2 treatment with cucurbit[7]uril-based supramolecular formulation
por: Kwong, Cheryl H.T., et al.
Publicado: (2021)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic
por: Singh, Shalinder, et al.
Publicado: (2020)

Chloroquine Ingestion to Prevent SARS-CoV-2 Infection: A Report of Two Cases
por: Graff, Jonathan, et al.
Publicado: (2021)

Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
por: Sacramento, Carolina Q., et al.
Publicado: (2022)

Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 Infection
por: Billoir, Paul, et al.
Publicado: (2021)

Retraction: Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
por: Frontiers Editorial Office,
Publicado: (2022)

SARS-CoV2 Infection and the Importance of Potassium Balance
por: Causton, Helen C.
Publicado: (2021)

Challenges and Issues of Anti-SARS-CoV-2 Vaccines
por: Blumental, Sophie, et al.
Publicado: (2021)

Effect of SARS-CoV-2 infection on asthma patients
por: Li, Xin-yu, et al.
Publicado: (2022)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Neutrophil Extracellular Traps in SARS-CoV2 Related Pneumonia in ICU Patients: The NETCOV2 Study
por: Godement, Mathieu, et al.
Publicado: (2021)

Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
por: Biguetti, Claudia, et al.
Publicado: (2020)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Host proviral and antiviral factors for SARS-CoV-2
por: Lv, Lu, et al.
Publicado: (2021)

Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
por: Beyer, Daniel K., et al.
Publicado: (2022)

Antiviral Effect of Budesonide against SARS-CoV-2
por: Heinen, Natalie, et al.
Publicado: (2021)

Theory and reality of antivirals against SARS-CoV-2
por: Zhao, Bo, et al.
Publicado: (2021)

Antiviral Efficacy of Pralatrexate against SARS-CoV-2
por: Bae, Joon-Yong, et al.
Publicado: (2021)

Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity
por: Kamat, Siya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qtl10i2e2309u8fcjivk2bmane